GlassScriptPhysician profile
Jacob Tony
NPI 1881815488
$1,016.27
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $785 · 2020: $187 · 2022: $34.13 · 2023: $10.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10.19.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $208.29 | 2019-2020 | |
| Biogen, INC. | $122.80 | 2019-2020 | |
| Genzyme Corporation | $120.34 | 2019-2020 | |
| Grifols USA, LLC | $65.84 | 2019-2020 | |
| Livanova USA, INC. | $60.13 | 2019-2020 | |
| Amgen INC. | $58.30 | 2019 | |
| Lilly USA, LLC | $43.38 | 2019-2020 | |
| Ucb, INC. | $40.03 | 2019-2020 | |
| Acadia Pharmaceuticals INC | $38.33 | 2019 | |
| Supernus Pharmaceuticals, INC. | $37.60 | 2019 | |
| Emd Serono, INC. | $37.36 | 2019-2020 | |
| Lundbeck LLC | $34.57 | 2019 | |
| Avion Pharmaceuticals | $34.13 | 2022 | |
| Eisai INC. | $32.06 | 2019-2020 | |
| Saol Therapeutics INC. | $17.88 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $16.11 | 2019 | |
| Amneal Pharmaceuticals LLC | $15.73 | 2019 | |
| Jazz Pharmaceuticals INC. | $11.71 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $11.49 | 2019 | |
| Bio Products Laboratory USA, INC. | $10.19 | 2023 | Gammaplex, Coagadex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Tony listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.